Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The $47 Billion Hole in Pharma's Near-Term Future
The $47 Billion Hole in Pharma's Near-Term Future
The $47 Billion Hole in Pharma's Near-Term Future
Submitted by
admin
on September 4, 2012 - 10:53am
Source:
Forbes
News Tags:
Pfizer
Merck
Eli Lilly
Bristol-Myers Squibb
Novo Nordisk
emerging markets
generics
Headline:
The $47 Billion Hole in Pharma's Near-Term Future
Do Not Allow Advertisers to Use My Personal information
